BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 14644119)

  • 41. Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
    Hrbáček J; Macek P; Ali-El-Dein B; Thalmann GN; Stenzl A; Babjuk M; Shaaban AA; Gakis G
    Urol Int; 2015; 94(1):45-9. PubMed ID: 25171129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of bladder cancer subtypes in neurogenic bladder tumors.
    Manach Q; Cussenot O; Rouprêt M; Gamé X; Chartier-Kastler E; Reus C; Camparo P; Compérat E; Phé V
    Can J Urol; 2018 Feb; 25(1):9161-9167. PubMed ID: 29524970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of uncommon malignant tumours of the bladder.
    Boyle H; Fléchon A; Droz JP
    Curr Opin Urol; 2011 Sep; 21(5):309-14. PubMed ID: 21814051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sarcomatoid carcinoma with small cell carcinoma component of the urinary bladder: a case report with review of the literature.
    Ishida M; Iwai M; Yoshida K; Kagotani A; Okabe H
    Int J Clin Exp Pathol; 2013; 6(8):1671-6. PubMed ID: 23923087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review.
    Maia MC; Hansen A; Alves C; Salah S
    Crit Rev Oncol Hematol; 2019 Mar; 135():76-84. PubMed ID: 30819449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors.
    Gluck G; Hortopan M; Stănculeanu D; Chiriță M; Stoica R; Sinescu I
    J Med Life; 2014 Jun; 7(2):211-4. PubMed ID: 25408727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges and opportunities in the management of non-urothelial bladder cancers.
    Brown JT; Narayan VM; Joshi SS; Harik L; Jani AB; Bilen MA
    Cancer Treat Res Commun; 2023; 34():100663. PubMed ID: 36527979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
    Zhou M; Epstein JI; Young RH
    Am J Surg Pathol; 2004 Jan; 28(1):94-100. PubMed ID: 14707870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology and etiology of premalignant and malignant urothelial changes.
    Cohen SM; Shirai T; Steineck G
    Scand J Urol Nephrol Suppl; 2000; (205):105-15. PubMed ID: 11144890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoma of the urinary bladder: a review of its diverse morphology.
    Eble JN; Young RH
    Semin Diagn Pathol; 1997 May; 14(2):98-108. PubMed ID: 9179971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymph node metastases in patients with urothelial carcinoma variants: influence of the specific variant on nodal histology.
    Rice KR; Koch MO; Kao CS; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Bihrle R; Cheng L
    Urol Oncol; 2015 Jan; 33(1):20.e23-20.e29. PubMed ID: 25047418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.